 "Q4 results")
Drug firm Morepen Laboratories on Tuesday reported an over two-fold rise in its consolidated net profit at Rs 26.76 crore for the quarter ended March 31, 2021, on account of higher revenue.
The company had posted a net profit of Rs 11.02 crore for the corresponding period of financial year 2019-20.
Its consolidated total revenue stood at Rs 290.76 crore for the quarter under consideration, up 39.53 per cent against Rs 208.38 crore a year ago, Morepen Laboratories said in a regulatory filing.
Shares of Morepen Laboratories were trading 4.95 per cent lower at Rs 65.25 apiece on BSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
